Geleen, Netherlands · Founded 2018 · Privately Held (backing)
Developer of metabolite-based biofungicides designed to control plant diseases through non-living microbial compounds. BioMosae is based in Geleen, Netherlands and was founded in 2018. Its last reported valuation was $2.5 million in Sep 2022. It has raised $3.7 million.
Last reported valuation
$2.5M
Oct 2026
Priced at
—
Total raised
$3.7M
Last round
—
Team — not yet on record
No current team members for BioMosae are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioMosae with a free account
·Watch BioMosae: the Monday email on marks, rounds and moves
